Voyager Therapeutics Heads Into Earnings With Sellers at the Top
VYGR enters today's Q1 2026 print with a contradictory setup: the stock fell 5% on Wednesday alone, yet options traders remain conspicuously calm, and the borrow market is about as relaxed as it gets. The most striking…